Tom Cotton (R-AR)

Securing America’s Drug Supply from Communist China Act

S. 4327 · Senate bill Health

A Republican bill with 1 Republican cosponsor · See the cosponsor

Last activity — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

In committee

Introduced and handed to a committee in the chamber it started in.

The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.

Its path through Congress

  1. Introduced
  2. In Committee

What this bill would do

The Securing America's Drug Supply from Communist China Act requires a regulatory review of pharmaceutical products from Chinese entities. The Secretary of Health and Human Services, working with the Office of National Security, will review drug applications to determine if sponsors are affiliated with the PRC, CCP, or PLA. If an application is submitted on or after enactment by a Chinese entity or a licensee of one, the Secretary may deny approval if the sponsor is found to be a PRC-, CCP-, or PLA-affiliated entity. The bill also mandates a review of certain applications submitted between January 1, 2016, and the date of enactment. Additionally, it directs the refusal and destruction of drugs imported by such affiliated entities, unless a waiver is granted due to drug shortages.

Yes

  • Scored +1

    Does this better protect the country from computer attacks?

    The bill addresses potential national security risks associated with foreign-controlled pharmaceutical entities.

The opposite

  • Scored -2

    Does this make health care easier to get in general?

    The bill could restrict the supply of certain medications by refusing and destroying imports from affiliated entities.

  • Scored -1

    Would business owners be better off under this?

    The regulatory burden and potential loss of assets via destruction of imported drugs could negatively impact pharmaceutical business owners.

  • Scored -1

    Does this make it easier to run a small business?

    The bill imposes regulatory barriers and potential destruction of goods that could impact businesses involved in the pharmaceutical supply chain.